TransMedics (TMDX) Change in Receivables (2018 - 2026)

TransMedics has reported Change in Receivables for 9 years, with the latest figure at $13.4 million in Q2 2026.

• On a quarterly basis, Change in Receivables rose 135.79% year-over-year to $13.4 million in Q2 2026; TTM through Jun 2026 was -$618000.0, a 102.66% decrease from a year earlier, with the FY2025 full-year figure at -$14.0 million, down 140.66% from the prior year.
• Change in Receivables was $13.4 million for Q2 2026 at TransMedics, up from $6.5 million in the prior quarter.
• The five-year high for Change in Receivables was $44.1 million in Q1 2025, with the low at -$37.5 million in Q2 2025.
• Average Change in Receivables over 5 years is $5.3 million, with a median of $7.2 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Change in Receivables surged 895.54% in 2022, then sank 4856.14% in 2025.
• Over 5 years, Change in Receivables stood at $5.4 million in 2022, then tumbled by 47.71% to $2.8 million in 2023, then soared by 178.15% to $7.8 million in 2024, then tumbled by 54.32% to $3.6 million in 2025, then soared by 274.87% to $13.4 million in 2026.
• The last three Change in Receivables figures came in at $13.4 million (Q2 2026), $6.5 million (Q1 2026), and $3.6 million (Q4 2025), per Business Quant data.